Hi Cash, The shorts were waiting for this on ISIS. People I don't think understand the data. I talked to the IR people at ISIS and they were delighted at the results but bemused by the market's reaction. Oh well, ISIS will recover. Hope you're doing well, t
As in my arch enemy Adam F., I'm actually a paid memeber at Cramers site. He has about 5 analyst on the site I follow and respect. On the paid site Adam put out a quick review and declared the drug not likely approvable due to liver problem being seen.
I would wager he has no idea ahout the patients in the trial were maxed out on statins dosages which are notorious for cauing Liver problems. Maybe he helped walk the price down with his in depth analysis (I joke).
I just added a few more ISIS shares at todays lower prices. I have to thank Adam F. for his contribution.